AnalyzeDirect

Suraiya Rahim Dubash¹, Nicholas Keat², Paola Mapelli¹, Frazer Twyman¹, Laurence Carroll¹, Kasia Kozlowski¹, Adil Al-nahhas¹, Azeem Saleem², Mickael Huiban², Ryan Janisch², Andrea Frilling¹, Rohini Sharma¹, Eric Aboagye¹. Clinical Translation of a ‘Click’ Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors. The Journal of Nuclear Medicine. 12 May 2016.

Publication Date
May 2016

How Analyze was Used
“Volumes of interest (VOIs) for as many of the possible ICRP 103 source organs were outlined, using the ANALYZE software package (version 11; Biomedical Imaging Resource, Mayo Clinic).”

Keywords
Neuroendocrine
PET/CT
Radiopharmaceuticals
18F-fluroethyl [Tyr3] octreotate analog
PET/CT imaging

Author Affiliation(s)
¹Imperial College, United Kingdom;
²Imanova Centre for Imaging Sciences, United Kingdom

Tags: Neuroendocrine Tumors/metabolism/secondary, PET-CT, Radiopharmaceuticals